Amarin (AMRN) is a late-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. This stock is trading up 3.6% at $14.98 in recent trading.
Today's Volume: 5.3 millionAverage Volume: 4.5 million Volume % Change: 104% Shares of AMRN are spiking higher as traders jump into the stock ahead of its highly anticipated date with the FDA on Thursday July 26. Amarin will go in front of the FDA for approval of its prescription fish-oil pill AMR101 for the treatment of patients with very high levels of triglycerides. >>Hot Biotech Stocks Traded by Hedge Funds From a technical perspective, AMRN is ripping higher here with above average volume. This move is quickly pushing AMRN within range of triggering a near-term breakout trade. That trade will hit once AMRN takes out some near-term overhead resistance at $15.40 with high-volume. Traders should look for long-biased if AMRN can sustain a move or close over $15.40 with volume that's near or above 4.5 million shares. At last check, AMRN has hit an intraday high of $15.15 and volume is well above its three-month average action. If we get that breakout soon, then AMRN could trade up towards $20 ahead of its FDA event. Amarin was also featured recently in "5 Big Stocks Ready to Slingshot Higher."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV